Pharsight

Ilumya patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US8404813 NA Engineered anti-IL-23P19 antibodies
Feb, 2031

(7 years from now)

Ingredients: TILDRAKIZUMAB-ASMN

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic